Wells Fargo & Company Aim Immuno Tech Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 1,147 shares of AIM stock, worth $286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,147

Previous 751 52.73%

Holding current value

$286

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.35 - $0.61 $138 - $241	396 Added 52.73%	1,147 $0
Q1 2024 May 10, 2024	BUY	$0.33 - $0.48 $1 - $2	6 Added 0.81%	751 $0
Q4 2023 Feb 09, 2024	BUY	$0.4 - $0.56 $8 - $11	20 Added 2.76%	745 $0
Q3 2023 Nov 13, 2023	SELL	$0.44 - $0.71 $10 - $17	-24 Reduced 3.2%	725 $0
Q2 2023 Aug 15, 2023	BUY	$0.4 - $0.67 $6 - $11	17 Added 2.32%	749 $0
Q1 2023 May 12, 2023	BUY	$0.32 - $0.77 $1 - $3	5 Added 0.69%	732 $0
Q4 2022 Feb 13, 2023	BUY	$0.31 - $0.6 $2 - $4	8 Added 1.11%	727 $0
Q3 2022 Nov 14, 2022	SELL	$0.57 - $0.81 $5,701 - $8,102	-10,003 Reduced 93.29%	719 $0
Q2 2022 Aug 12, 2022	BUY	$0.78 - $1.27 $340 - $553	436 Added 4.24%	10,722 $8,000
Q1 2022 May 16, 2022	SELL	$0.67 - $1.18 $1,010 - $1,779	-1,508 Reduced 12.79%	10,286 $11,000
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.96 $920 - $1,961	1,001 Added 9.27%	11,794 $10,000
Q3 2021 Nov 15, 2021	SELL	$1.91 - $2.17 $30 - $34	-16 Reduced 0.15%	10,793 $22,000
Q2 2021 Aug 16, 2021	BUY	$1.93 - $2.39 $13,594 - $16,835	7,044 Added 187.09%	10,809 $23,000
Q1 2021 May 13, 2021	SELL	$1.88 - $2.82 $69,174 - $103,761	-36,795 Reduced 90.72%	3,765 $9,000
Q4 2020 Feb 09, 2021	SELL	$1.68 - $2.45 $3,659 - $5,336	-2,178 Reduced 5.1%	40,560 $73,000
Q3 2020 Nov 05, 2020	BUY	$1.77 - $3.88 $10,018 - $21,960	5,660 Added 15.27%	42,738 $92,000
Q2 2020 Aug 13, 2020	BUY	$1.9 - $2.94 $68,443 - $105,907	36,023 Added 3414.5%	37,078 $91,000
Q1 2020 May 14, 2020	BUY	$0.56 - $6.1 $590 - $6,435	1,055 New	1,055 $3,000

Others Institutions Holding AIM

# of Institutions

Shares Held

8.42M

Call Options Held

Put Options Held

View Full List

About AIM ImmunoTech Inc.

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $12M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

More about AIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Aim Immuno Tech Inc. Transaction History